Thursdy, April 28, 2022
6:00 PM to 8:00 PM Central Time

Live virtual Zoom meeting
 

Agenda

6:00 pm - Welcome and overview of agenda
(Dr. Costa and Caroline Kornhauser)

6:05 pm - Treating newly diagnosed multiple myeloma
(Dr. Baljevic and Dr. Biltibo)

6:30 pm – Q&A  

6:40 pm - Treating early relapse myeloma
 (Dr. Elsedawy and Dr. Todorova)

7:05 pm – Q&A 

7:15 pm – Treating triple class refractory myeloma
 (Dr. Bal and Dr. Pywell)

7:40 pm –  Clinical Trials Support Services and other LLS Resources 
(Laura Romundstad and Caroline Kornhauser)

7:50 pm –  Q&A

7:55 pm –  Closing  

Target Audience

This CE activity is intended for oncologists, advanced practice providers, pharmacists, nurses, and other community-based healthcare professionals involved in the care of patients with myeloma.
 

    Learning Objectives

    After completing this CE activity, the participant should be better able to:

    • Describe the latest developments in treating multiple myeloma, including new and emerging treatment options
    • Identify strategies for treating newly diagnosed,  early relapse and triple class refractory myeloma
    • Explain the role of CAR T-cell therapy and clinical trials in treatment
    • Provide patient education and support referrals to LLS and other organizations

    Speakers

    Susan Bal, MD
    Assistant Professor 
    Hematology, Medical Oncology
    The University of Alabama at Birmingham
    Birmingham, AL

    Muhamed Baljevic, MD, FACP
    Division of Hematology-Oncology
    Department of Medicine
    Director, Plasma Cell Disorders Research and Vanderbilt Amyloidosis (VAMP) Programs
    Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas
    Vanderbilt-Ingram Cancer Center
    Vanderbilt University Medical Center
    Nashville, TN 

    Eden Ayele Biltibo, MD, MS
    Hematology/Oncology Fellow
    Vanderbilt-Ingram Cancer Center
    Vanderbilt University Medical Center
    Nashville, TN 

    Noura Elsedawy, MD
    Assistant Professor
    Medical Oncology
    UTHSC
    University of Tennessee
    Memphis, TN

    Caroline Kornhauser, MPH
    Senior Manager, Professional Education
    The Leukemia & Lymphoma Society
    Rye Brook, NY

    Cameron Pywell, MD
    Fellow
    Division of Hematology Oncology 
    The University of Alabama at Birmingham
    Birmingham, AL

    Laura Romundstad, MSN, RN, CRNP, AOCNP
    Clinical Trial Nurse Navigator
    Clinical Trial Support Center
    The Leukemia & Lymphoma Society
    Rye Brook, NY

    Lina Todorova, MD
    Hematology/Oncology Fellow
    UTHSC
    University of Tennessee
    Memphis, TN

    Advisory Group Co-Chairs

    Luciano J. Costa, MD, PhD 
    Professor of Medicine
    Director Multiple Myeloma Program
    The University of Alabama at Birmingham
    Birmingham, AL

    Brion V. Randolph, MD
    Associate Professor and Director of Cell & Gene Therapy
    The University of Tennessee Health Science Center
    Division of Hematology & Oncology
    College of Medicine
    Memphis, TN 

    This Activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
    There is no commercial support associated with this CE activity.
     

    For questions, concerns, or assistance for people with disabilites or grievances, please contact us at: profed@LLS.org.

    Follow LLS